SEC Form 4 · accession 0001645627-18-000040
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Jul 24, 2018
Accepted (ET)
Aug 2, 2018 · 8:26 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 24, 2018 | P | 1,000 | $0.0346 | A | 25,209,498 | D | |
| Common Stock | Jul 24, 2018 | P | 1,000 | $0.0338 | A | 25,210,498 | D | |
| Common Stock | Jul 24, 2018 | P | 1,000 | $0.0338 | A | 25,211,498 | D | |
| Common Stock | Jul 26, 2018 | P | 1,000 | $0.0328 | A | 25,212,498 | D | |
| Common Stock | Jul 26, 2018 | P | 1,000 | $0.033 | A | 25,213,498 | D |
Table II — derivative securities
No Table II lines on this filing.